Skip to main content
NCBI home page
Infectious Diseases in Obstetrics and Gynecology logoLink to Infectious Diseases in Obstetrics and Gynecology
. 1996;4(1):36–42. doi: 10.1155/S1064744996000099

Ethical Issues Associated With Routine Screening and Prophylaxis for Group B Streptococcus in Pregnancy

Michael K Yancey 1,✉, Anne Schuchat 3, Patrick Duff 2
PMCID: PMC2364458  PMID: 18476063

Abstract

An increased awareness of the impact of group B streptococcus (GBS) infection on neonatal outcome has prompted several seemingly discordant committee recommendations. Intrapartum antibiotics are effective in reducing the risk of neonatal morbidity when administered to a colonized woman who has a clinical condition that places her neonate at high risk for early-onset sepsis. However, less is known about the efficacy of prophylactic antibiotics in the colonized woman who does not have obvious risk factors. Some authorities have suggested that providers refrain from administering intrapartum antibiotics to colonized women who do not have any of these risk factors, primarily due to concerns about potential adverse reactions, selection of resistant pathogens, and cost-effectiveness. These recommendations may conflict with the desires of an informed woman who weighs the real, albeit low, risk for serious neonatal disease against the lower perceived risk of adverse maternal sequelae from allergic reactions to the antimicrobial agents. Selective prophylaxis for GBS disease that is limited to the colonized parturient with risk factors has the potential for creating conflict because maternal beneficence-based obligations of the physician may be at odds with maternal autonomy-based obligations. We believe that, given all currently available information, providers have a moral obligation to discuss GBS screening and treatment issues with patients. The potential for conflict between patient and physician at the time of delivery can be minimized through the use of preventive ethics, allowing patients to develop advance directives regarding intrapartum management within the confines of reasonable and cost-effective care. Until a consensus is reached among experts, the most prudent approach would be to address such issues proactively and individualize care based upon the overall estimation and anticipation of risk as well as the patient's specific desires.

Full Text

The Full Text of this article is available as a PDF (649.6 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Allen U. D., Navas L., King S. M. Effectiveness of intrapartum penicillin prophylaxis in preventing early-onset group B streptococcal infection: results of a meta-analysis. CMAJ. 1993 Dec 1;149(11):1659–1665. [PMC free article] [PubMed] [Google Scholar]
  2. American Academy of Pediatrics Committee on Infectious Diseases and Committee on Fetus and Newborn: Guidelines for prevention of group B streptococcal (GBS) infection by chemoprophylaxis. Pediatrics. 1992 Nov;90(5):775–778. [PubMed] [Google Scholar]
  3. Ascher D. P., Becker J. A., Yoder B. A., Weisse M., Waecker N. J., Heroman W. M., Davis C., Fajardo J. E., Fischer G. W. Failure of intrapartum antibiotics to prevent culture-proved neonatal group B streptococcal sepsis. J Perinatol. 1993 May-Jun;13(3):212–216. [PubMed] [Google Scholar]
  4. Boyer K. M., Gotoff S. P. Strategies for chemoprophylaxis of GBS early-onset infections. Antibiot Chemother (1971) 1985;35:267–280. doi: 10.1159/000410380. [DOI] [PubMed] [Google Scholar]
  5. Chervenak F. A., McCullough L. B., Chervenak J. L. Prenatal informed consent for sonogram: an indication for obstetric ultrasonography. Am J Obstet Gynecol. 1989 Oct;161(4):857–860. doi: 10.1016/0002-9378(89)90735-7. [DOI] [PubMed] [Google Scholar]
  6. Chervenak F. A., McCullough L. B. Clinical guides to preventing ethical conflicts between pregnant women and their physicians. Am J Obstet Gynecol. 1990 Feb;162(2):303–307. doi: 10.1016/0002-9378(90)90374-g. [DOI] [PubMed] [Google Scholar]
  7. Garland S. M., Fliegner J. R. Group B streptococcus (GBS) and neonatal infections: the case for intrapartum chemoprophylaxis. Aust N Z J Obstet Gynaecol. 1991 May;31(2):119–122. doi: 10.1111/j.1479-828x.1991.tb01797.x. [DOI] [PubMed] [Google Scholar]
  8. Gigante J., Hickson G. B., Entman S. S., Oquist N. L. Universal screening for group B streptococcus: recommendations and obstetricians' practice decisions. Obstet Gynecol. 1995 Mar;85(3):440–443. doi: 10.1016/0029-7844(94)00422-A. [DOI] [PubMed] [Google Scholar]
  9. Heim K., Alge A., Marth C. Anaphylactic reaction to ampicillin and severe complication in the fetus. Lancet. 1991 Apr 6;337(8745):859–860. doi: 10.1016/0140-6736(91)92574-l. [DOI] [PubMed] [Google Scholar]
  10. Idsoe O., Guthe T., Willcox R. R., de Weck A. L. Nature and extent of penicillin side-reactions, with particular reference to fatalities from anaphylactic shock. Bull World Health Organ. 1968;38(2):159–188. [PMC free article] [PubMed] [Google Scholar]
  11. Katz V. L., Moos M. K., Cefalo R. C., Thorp J. M., Jr, Bowes W. A., Jr, Wells S. D. Group B streptococci: results of a protocol of antepartum screening and intrapartum treatment. Am J Obstet Gynecol. 1994 Feb;170(2):521–526. doi: 10.1016/s0002-9378(94)70221-7. [DOI] [PubMed] [Google Scholar]
  12. Mercer B. M., Ramsey R. D., Sibai B. M. Prenatal screening for group B Streptococcus. I. Impact of antepartum screening on antenatal prophylaxis and intrapartum care. Am J Obstet Gynecol. 1995 Sep;173(3 Pt 1):837–841. doi: 10.1016/0002-9378(95)90351-8. [DOI] [PubMed] [Google Scholar]
  13. Mercer B. M., Ramsey R. D., Sibai B. M. Prenatal screening for group B Streptococcus. II. Impact of antepartum screening and prophylaxis on neonatal care. Am J Obstet Gynecol. 1995 Sep;173(3 Pt 1):842–846. doi: 10.1016/0002-9378(95)90352-6. [DOI] [PubMed] [Google Scholar]
  14. Ohlsson A., Myhr T. L. Intrapartum chemoprophylaxis of perinatal group B streptococcal infections: a critical review of randomized controlled trials. Am J Obstet Gynecol. 1994 Mar;170(3):910–917. doi: 10.1016/s0002-9378(94)70307-8. [DOI] [PubMed] [Google Scholar]
  15. Pyati S. P., Pildes R. S., Jacobs N. M., Ramamurthy R. S., Yeh T. F., Raval D. S., Lilien L. D., Amma P., Metzger W. I. Penicillin in infants weighing two kilograms or less with early-onset Group B streptococcal disease. N Engl J Med. 1983 Jun 9;308(23):1383–1389. doi: 10.1056/NEJM198306093082303. [DOI] [PubMed] [Google Scholar]
  16. Pylipow M., Gaddis M., Kinney J. S. Selective intrapartum prophylaxis for group B streptococcus colonization: management and outcome of newborns. Pediatrics. 1994 Apr;93(4):631–635. [PubMed] [Google Scholar]
  17. Rouse D. J., Goldenberg R. L., Cliver S. P., Cutter G. R., Mennemeyer S. T., Fargason C. A., Jr Strategies for the prevention of early-onset neonatal group B streptococcal sepsis: a decision analysis. Obstet Gynecol. 1994 Apr;83(4):483–494. doi: 10.1097/00006250-199404000-00001. [DOI] [PubMed] [Google Scholar]
  18. Schuchat A., Deaver-Robinson K., Plikaytis B. D., Zangwill K. M., Mohle-Boetani J., Wenger J. D. Multistate case-control study of maternal risk factors for neonatal group B streptococcal disease. The Active Surveillance Study Group. Pediatr Infect Dis J. 1994 Jul;13(7):623–629. doi: 10.1097/00006454-199407000-00008. [DOI] [PubMed] [Google Scholar]
  19. Siegel J. D., McCracken G. H., Jr, Threlkeld N., Milvenan B., Rosenfeld C. R. Single-dose penicillin prophylaxis against neonatal group B streptococcal infections. A controlled trial in 18,738 newborn infants. N Engl J Med. 1980 Oct 2;303(14):769–775. doi: 10.1056/NEJM198010023031401. [DOI] [PubMed] [Google Scholar]
  20. Weisman L. E., Stoll B. J., Cruess D. F., Hall R. T., Merenstein G. B., Hemming V. G., Fischer G. W. Early-onset group B streptococcal sepsis: a current assessment. J Pediatr. 1992 Sep;121(3):428–433. doi: 10.1016/s0022-3476(05)81801-3. [DOI] [PubMed] [Google Scholar]
  21. Yancey M. K., Duff P. An analysis of the cost-effectiveness of selected protocols for the prevention of neonatal group B streptococcal infection. Obstet Gynecol. 1994 Mar;83(3):367–371. [PubMed] [Google Scholar]
  22. Yancey M. K., Duff P., Clark P., Kurtzer T., Frentzen B. H., Kubilis P. Peripartum infection associated with vaginal group B streptococcal colonization. Obstet Gynecol. 1994 Nov;84(5):816–819. [PubMed] [Google Scholar]

Articles from Infectious Diseases in Obstetrics and Gynecology are provided here courtesy of Wiley

RESOURCES